Type 2 diabetes trials in Bulgaria

In Bulgaria 10 Also abroad 1200

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
AMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Gabrovo, Ruse, Sliven, Smolyan, Sofia, Varna
Age
18 years and over
People
595 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525472-26-00 · EU 2026-525472-26-00
Phase 3Taking people
AMBITION 4: A research study investigating how well zenagamtide at lower dose levels lowers blood sugar and body weight compared to semaglutide at lower dose levels in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Blagoevgrad, Burgas, Pazardzhik, Pleven, Sofia, Stara Zagora
Age
18 years and over
People
245 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525474-20-00 · EU 2026-525474-20-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Montana, Pleven, Plovdiv, Sofia, Varna, Yambol
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Dimitrovgrad, Dupnitsa, Gabrovo, Kyustendil, Pernik, Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora, Yambol
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Where
Plovdiv, Sofia, Sofiya, Yambol
Age
18 years and over
People
1,200 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Burgas, Kazanlak, Kyustendil, Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora, Varna, Veliko Tirnovo
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Dupnitsa, Haskovo, Kyustendil, Pleven, Plovdiv, Ruse, Stara Zagora, Varna
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Burgas, Dimitrovgrad, Dobrich, Dupnitsa, Plovdiv, Smolyan, Sofia, Stara Zagora, Yambol
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Where
Dupnitsa, Kozloduy, Plovdiv, Sofia, Stara Zagora, Veliko Tirnovo, Yambol
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Bankya, Kozloduy, Smolyan, Sofia, Sofiya, Varna
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00